Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-grade Inflammatory Challenge and Social Behavior
NCT05654441Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of influenza vaccine (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Interleukin-6 Levels at 24 hours, Interleukin-10 Levels at 24 hours and 2 more. Started Oct 2022; status: completed.
02
Drugs
influenza vaccine
Beyond the preview
Go deeper on NCT05654441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05654441.